InterCure Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Alex Rabinovich

Chief executive officer

₪1.4m

Total compensation

CEO salary percentage51.5%
CEO tenure5.9yrs
CEO ownership26.6%
Management average tenureno data
Board average tenure6.3yrs

Recent management updates

Recent updates

These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

Feb 16
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

What InterCure Ltd.'s (TLV:INCR) P/E Is Not Telling You

Sep 19
What InterCure Ltd.'s (TLV:INCR) P/E Is Not Telling You

Here's Why InterCure (TLV:INCR) Can Manage Its Debt Responsibly

Aug 22
Here's Why InterCure (TLV:INCR) Can Manage Its Debt Responsibly

InterCure (TLV:INCR) Seems To Use Debt Quite Sensibly

Feb 14
InterCure (TLV:INCR) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

What Percentage Of InterCure Ltd (TLV:INCR) Shares Do Insiders Own?

Mar 08
What Percentage Of InterCure Ltd (TLV:INCR) Shares Do Insiders Own?

Shareholders Are Raving About How The InterCure (TLV:INCR) Share Price Increased 936%

Jan 12
Shareholders Are Raving About How The InterCure (TLV:INCR) Share Price Increased 936%

Is InterCure (TLV:INCR) Using Debt Sensibly?

Dec 04
Is InterCure (TLV:INCR) Using Debt Sensibly?

CEO Compensation Analysis

How has Alex Rabinovich's remuneration changed compared to InterCure's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-₪66m

Mar 31 2024n/an/a

-₪61m

Dec 31 2023₪1m₪728k

-₪62m

Sep 30 2023n/an/a

-₪20m

Jun 30 2023n/an/a

₪21m

Mar 31 2023n/an/a

₪32m

Dec 31 2022₪1m₪500k

₪45m

Sep 30 2022n/an/a

₪33m

Jun 30 2022n/an/a

₪24m

Mar 31 2022n/an/a

₪15m

Dec 31 2021₪180k₪180k

₪5m

Sep 30 2021n/an/a

₪17m

Jun 30 2021n/an/a

₪20m

Mar 31 2021n/an/a

₪13m

Dec 31 2020₪122k₪122k

-₪37m

Compensation vs Market: Alex's total compensation ($USD384.95K) is about average for companies of similar size in the IL market ($USD428.07K).

Compensation vs Earnings: Alex's compensation has increased whilst the company is unprofitable.


CEO

Alex Rabinovich (53 yo)

5.9yrs

Tenure

₪1,414,000

Compensation

Mr. Alexander Rabinovich, also known as Alex, is Chief Executive Officer and Director of InterCure Ltd. since January 1, 2019 and October 2018 respectively. Mr. Rabinovich is Chief Executive Officer and Di...


Board Members

NamePositionTenureCompensationOwnership
Alexander Rabinovich
CEO & Director6.2yrs₪1.41m26.58%
₪ 76.5m
Ehud Barak
Chairman of the Board6.3yrs₪445.00k2.25%
₪ 6.5m
Alon Granot
Non-Executive Director4.1yrs₪152.00kno data
David Salton
Independent Director10yrs₪201.00k0.0088%
₪ 25.5k
Lennie Grinbaum
Independent External Director9.3yrs₪201.00k0.024%
₪ 67.9k
Gideon Hirschfeld
Independent External Director6.3yrs₪201.00k0.0088%
₪ 25.5k

6.3yrs

Average Tenure

60.5yo

Average Age

Experienced Board: INCR's board of directors are considered experienced (6.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:27
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InterCure Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matt BottomleyCanaccord Genuity
Vivien AzerTD Cowen